On March 14, 2016, Nuvectra Corporation completed its spin-off from Greatbatch, Inc. into an independent, publicly-traded neurostimulation medical device company. The company is headquartered in Plano, Texas, with additional locations in Denver, Ann Arbor, and Minneapolis.
Nuvectra currently trades on the NASDAQ Global Market (NASDAQ) under the ticker symbol "NVTR."
Data provided by Nasdaq. Minimum 15 minutes delayed.
December 13, 2017
Nuvectra Achieves 1,000th Algovita® SCS System Implantation in U.S.
PLANO, Texas, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that the company’s Algovita® Spinal Cord Stimulation (SCS) system has now been implanted in 1,000 patients across the U.S. seeking non-pharmaceutical relief from chronic pain. The milestone procedure was performed on a SCS patient by Giancarlo Barolat, MD, Neuromodulation Medical Director at Presbyterian/St. Luke’s Medical Center located in Denver, Colo
November 15, 2017
Nuvectra to Present at the 29th Annual Piper Jaffray Healthcare Conference
PLANO, Texas, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at the 29th Annual Piper Jaffray Healthcare Conference. Event: 29th Annual Piper Jaffray Healthcare Conference Date: Tuesday, November 28, 2017
The Ruth Group
|There are currently no events scheduled.|